Zoledronic acid (monohydrate)

$96$156

Products Details

Product Description

– Zoledronic acid monohydrate (Zoledronate monohydrate) is a third-generation bisphosphonate (BP), with potent anti-resorptive activity. Zoledronic acid monohydrate inhibits the differentiation and apoptosis of osteoclasts. Zoledronic acid monohydrate also has anti-cancer effects[1].

Web ID

– HY-13777A

Storage Temperature

– -20°C, 3 years; 4°C, 2 years (Powder)

Shipping

– Room Temperature

Applications

– Cancer-programmed cell death

Molecular Formula

– C5H12N2O8P2

Citations

– Dis Markers. 2021 Oct 15;2021:5838582.|Gut Microbes. 2023 Dec;15(2):2249143.|ACS Nano. 2023 Jul 10.|Int Immunopharmacol. September 2022, 109030.|Med Oncol. 2023 Apr 10;40(5):141.|Oxid Med Cell Longev. 2021 Mar 31.

References

– [1]Shea GKH, et al. Oral Zoledronic acid bisphosphonate for the treatment of chronic low back pain with associated Modic changes: A pilot randomized controlled trial. J Orthop Res. 2022 Feb 23.|[2]Lianwei Wang, et al. Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review. BMC Cancer. 2020; 20: 1059.|[3]Hyung Joon Kim, et al. Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis. Int J Mol Sci. 2019 Mar; 20(6): 1467.|[4]Xiao-Lin Huang, et al. Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways. Int J Mol Med. 2019 Aug;44(2):582-592.|[5]XIN HUANG, et al. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Mol Med Rep. 2016 Jan; 13(1): 613-622.|[6]Samantha Pozzi, et al. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res. 2009 Sep 15;15(18):5829-39.

CAS Number

– 165800-06-6

Molecular Weight

– 290.10

Compound Purity

– 98.0

SMILES

– OC(P(O)(O)=O)(P(O)(O)=O)CN1C=CN=C1.[H]O[H]

Clinical Information

– Launched

Research Area

– Cancer; Metabolic Disease

Solubility

– DMSO : 1 mg/mL (ultrasonic;warming;heat to 60°C)

Target

– Apoptosis;Autophagy;Bacterial

Pathway

– Anti-infection;Apoptosis;Autophagy

Product type

– Reference compound

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

=

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.

=